SDPD Finds a Way Around State Law Limiting DNA Collection From Juveniles
By Kelly Davis,
Voice of San Diego
| 02. 15. 2017
When it comes to collecting DNA from criminal offenders, California law is especially protective of juveniles.
While 2004’s Proposition 69 broadened police authority to collect DNA without a warrant, it put limits on when DNA can be collected from juveniles. Only if a youth has been found guilty of a felony or required to register as a sex offender can law enforcement obtain a DNA sample.
But the San Diego Police Department has found a way around state law. The department maintains its own database — one that’s not linked to state or federal DNA databases. According to department policy, as long as a DNA profile remains in the local database, officers can collect DNA from anyone for “investigative purposes.” The policy requires only that officers get a signed consent from the minor. It doesn’t require them to notify the minor’s parent or guardian until after the sample’s been taken.
A lawsuit filed Tuesday by the ACLU of San Diego and Imperial Counties challenges that policy, and argues that a juvenile is incapable of providing informed consent, especially if he...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
